Our Videos



Pharma Insider II
Opposition research
(read transcript)


Pharma Insider I
Off-label promotion under the radar
(read transcript)

The Art of Medical Writing
Pharma's anonymous writers

Drug Reps Talk Shop II
Drug reps continue their chat

Drug Reps Talk Shop I Selling drugs to docs

Director of PharmedOut Explains the Project

Zyprexa Drug Rep Tells All Shahram Ahari describes how he sold the drug
News

No More Free Rx Samples
Carolinas HealthCare System leads the way Carolina Observer
Glaxo 'Downplayed' Warning
Abacavir doubles MI risk Independent
Physician, Reveal Thyself
Heart stent studies don't disclose funding Businessweek (PLoS One study)
Protecting Human Subjects
US clinical trials no longer required Center for Science in the Public
FDA Slow To Issue DTCA Warnings
Ads discontinued before letters received Pharmalot (read GAO report)
Celebrex Doesn't Prevent Memory Loss
Nor does naproxen Bloomberg (Archives of Neurology study)
Pfizer to Disclose Grants
With Lilly, supports revised Sunshine Act Pharmatimes
Migraine Medicines Problematic
Associated with serotonin syndrome Bloomberg (NEJM study)
Stealth Marketers
Shilling for pharma on NPR Slate
Psychiatry Handbook Linked to Drug Industry
COIs in over half of new working group members NYT (read Center for Science in the Public Interest article)
Legislators: Glaxo Letter on Gift Ban May Backfire
Does MA have a “strong anti-biopharmaceutical streak?” Boston Herald (read additional article)
Glaxo Tries to Corner Weight Loss Market
Tells FDA to deny dietary supplement claims Pharmalot

Commentary

Prescription Tracking and Public Health
AMA’s PDRP inadequate JGIM
Click HERE to read the entire news archives
All content on this site is © 2006 by PharmedOut * (p) 202-687-1191 * (f) 202-687-7407 * Georgetown University
Department of Physiology and Biophysics * Box 571460 * Washington, DC 20057-1460